Abstract
Susceptibility to ampicillin and chloramphenicol in vitro has been determined for Haemophilus influenzae strains isolated from blood and/or cerebrospinal fluid cultures of patients admitted to two Atlanta hospitals from 1 January 1974 to 31 March 1975. Since the appearance of ampicillin-resistant strains of this organism in early 1974, chloramphenicol has been used in these hospitals as initial therapy for severe infection due to H. influenzae. Strains from five of 94 patients were resistant to ampicillin (minimum inhibitory concentration [MIC] ≥ 12.5 μg/ml), but all strains were susceptible to chloramphenicol (MIC < 2 μg/ml). The first 35 strains studied, including three resistant to ampicillin, were also tested for in vitro susceptibility to trimethoprim-sulfamethoxazole; all were highly susceptible (MIC ≤ 0.0312 μg of trimethoprim and 0.625 μg of sulfamethoxazole per ml).
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Catlin B. W. Iodometric detection of Haemophilus influenzae beta-lactamase: rapid presumptive test for ampicillin resistance. Antimicrob Agents Chemother. 1975 Mar;7(3):265–270. doi: 10.1128/aac.7.3.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cavanagh P., Morris C. A., Mitchell N. J. Letter: Chloramphenicol resistance in haemophilus species. Lancet. 1975 Mar 22;1(7908):696–696. doi: 10.1016/s0140-6736(75)91810-3. [DOI] [PubMed] [Google Scholar]
- Elwell L. P., De Graaff J., Seibert D., Falkow S. Plasmid-linked ampicillin resistance in haempohilus influenza type b. Infect Immun. 1975 Aug;12(2):404–410. doi: 10.1128/iai.12.2.404-410.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Farrar W. E., Jr, O'Dell N. M. Beta-lactamase activity in ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother. 1974 Nov;6(5):625–629. doi: 10.1128/aac.6.5.625. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Katz S. L. Ampicillin-resistant Hemophilus influenzae type b: a status report. Pediatrics. 1975 Jan;55(1):6–8. [PubMed] [Google Scholar]
- Khan W., Ross S., Rodriguez W., Controni G., Saz A. K. Haemophilus influenzae type B resistant to ampicillin. A report of two cases. JAMA. 1974 Jul 15;229(3):298–301. [PubMed] [Google Scholar]
- Kirven L. A., Thornsberry C. In vitro susceptibility of Haemophilus influenzae to trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother. 1974 Dec;6(6):869–870. doi: 10.1128/aac.6.6.869. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Medeiros A. A., O'Brien T. F. Ampicillin-resistant Haemophilus influenzae type B possessing a TEM-type beta-lactamase but little permeability barrier to ampicillin. Lancet. 1975 Mar 29;1(7909):716–719. doi: 10.1016/s0140-6736(75)91630-x. [DOI] [PubMed] [Google Scholar]
- Nelson J. D. Editorial: Should ampicillin be abandoned for treatment of Haemophilus influenzae disease? JAMA. 1974 Jul 15;229(3):322–324. [PubMed] [Google Scholar]
- Schiffer M. S., MacLowry J., Schneerson R., Robbins J. B., McReynolds J. W., Thomas W. J., Bailey D. W., Clarke E. J., Jr, Mueller E. J., Escamilla J. Clinical, bacteriological, and immunological characterisation of ampicillin-resistant Haemophilus influenzae type B. Lancet. 1974 Aug 3;2(7875):257–259. doi: 10.1016/s0140-6736(74)91416-0. [DOI] [PubMed] [Google Scholar]
- Thornsberry C., Kirven L. A. Ampicillin resistance in Haemophilus influenzae as determined by a rapid test for beta-lactamase production. Antimicrob Agents Chemother. 1974 Nov;6(5):653–654. doi: 10.1128/aac.6.5.653. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tomeh M. O., Starr S. E., McGowan J. E., Jr, Terry P. M., Nahmias A. J. Ampicillin-resistant Haemophilus influenzae type B infection. JAMA. 1974 Jul 15;229(3):295–297. [PubMed] [Google Scholar]